Biotechnology startup Tiamat Sciences has announced its $3 million seed financing round led by Silicon Valley venture capital firm True Ventures with participation from Social Impact Capital and Cantos. “Our technology can help to promote animal-free alternatives not only for food but also for the pharmaceutical industry,” said France-Emmanuelle Adil, founder and CEO of Tiamat…